Targeting Glucosylceramide Synthase Reverses Multi-Drug Resistance in Breast Carcinoma Cells

SUN Yan-lin,ZHOU Geng-yin,ZHAO Sheng-mei,Mu Kun,ZHANG Cui-juan,ZHANG Xiao-fang,XIANG Lei

DOI: https://doi.org/10.3969/j.issn.1671-7554.2005.10.001

2005-01-01

Abstract:Objective: To study the effect and mechanism of targeting glucosylceramide synthase(GCS) on multi-drug resistance in breast carcinoma. Methods: GCS antisense oligodeoxynucleotide (GCS ASODN)was used to transfect human drug-resistant breast carcinoma cells MCF-7/AdrR, the mRNA expression of GCS and MDR was studied by using RT-PCR analysis, the protein expression of GCS and P-gp was studied by immunocytochemistry. Flow cytemetry analysis was used to detect the ratio of apoptosis and cell cycle. The alteration of Caspase-3 activity was assessed by Caspase-3 activity assess method. Results: After MCF-7/AdrR cells transfected with GCS ASODN, GCS and MDR1 expression was 0.3 and 0.7 respectively, the positive rate of GCS and P-gp expression was 23% and 33% respectively. There was significant difference of GCS and MDR1 expression compared with the control(P0.05). Cell cycle was not altered, but the apoptosis of cells increased to 13.7±4.1, the activity of Caspase-3 increased to 0.0725±0.0003,(P0.01). Conclusion: Targeting GCS can reverse multi-drug resistance in breast carcinoma efficiently by inhibiting GCS directly ,down-regulating MDR1mRNA and protein expression indirectly, activating Caspase-3 and inducing apoptosis of drug-resistant cells.